stoxline Quote Chart Rank Option Currency Glossary
PMV Pharmaceuticals, Inc. (PMVP)
2.31  0.01 (0.43%)    12-08 16:00
Open: 2.29
High: 2.355
Volume: 246,027
Pre. Close: 2.3
Low: 2.26
Market Cap: 118(M)
Technical analysis
2023-12-08 4:45:27 PM
Short term     
Mid term     
Targets 6-month :  3.04 1-year :  3.56
Resists First :  2.6 Second :  3.04
Pivot price 2.32
Supports First :  2.1 Second :  1.79
MAs MA(5) :  2.31 MA(20) :  2.28
MA(100) :  4.81 MA(250) :  5.8
MACD MACD :  -0.1 Signal :  -0.2
%K %D K(14,3) :  32.5 D(3) :  37
RSI RSI(14): 46.9
52-week High :  10.22 Low :  1.17
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ PMVP ] has closed above bottom band by 46.6%. Bollinger Bands are 85.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 25 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.36 - 2.37 2.37 - 2.39
Low: 2.23 - 2.25 2.25 - 2.26
Close: 2.29 - 2.31 2.31 - 2.34
Company Description

PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also developing mutant p53 programs, including Wild-type p53 Induced-Phosphatase, R282W, and R273H, as well as other p53 hotspot mutations. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Cranbury, New Jersey.

Headline News

Mon, 20 Nov 2023
Is PMV Pharmaceuticals Inc (PMVP) Stock About to Get Hot Monday? - InvestorsObserver

Thu, 09 Nov 2023
PMV Pharmaceuticals Reports Third Quarter 2023 Financial Results and Corporate Highlights - Yahoo Finance

Thu, 09 Nov 2023
PMV Pharmaceuticals Inc (PMVP) Reports Q3 2023 Financial Results and Corporate Updates - Yahoo Finance

Mon, 16 Oct 2023
PMV Pharmaceuticals, Inc. (PMVP) Loses -70.19% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance

Thu, 12 Oct 2023
Healthcare Stocks on the Move Thursday: OPGN, EDSA, UPC, WINT, TPST, PHIO, PMVP, PROK - InvestorsObserver

Fri, 06 Oct 2023
Wall Street Analysts See a 239.26% Upside in PMV Pharmaceuticals, Inc. (PMVP): Can the Stock Really Move This ... - Yahoo Finance

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Shares Out 51 (M)
Shares Float 37 (M)
Held by Insiders 2.1 (%)
Held by Institutions 118.5 (%)
Shares Short 1,590 (K)
Shares Short P.Month 5,720 (K)
Stock Financials
EPS -1.56
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 4.63
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) -18.9 %
Return on Equity (ttm) -29.1 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) -1.6
Qtrly Earnings Growth 0 %
Operating Cash Flow -59 (M)
Levered Free Cash Flow -38 (M)
Stock Valuations
PE Ratio -1.49
PEG Ratio -0.1
Price to Book value 0.49
Price to Sales 0
Price to Cash Flow -2.01
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android